sellWeak
William R Larue sold $151 of TCON
director at Tracon Pharmaceuticals, Inc.. 120 shares at an average of $1.26, traded Dec 21, 2022, filed Jan 19, 2023.
Warning score
15Value
$151
120 shares
Holdings after
7,763
-2% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleDirector
- 0Trade size$151 at market
- 0Share of holdings soldSold 1.5% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001209191-23-003933, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 21, 2022 | SOpen-market sale Common Stock | -120 | $1.26 | $151 | 7,763 | Jan 19, 2023 |
Related signals
Other insiders at Tracon Pharmaceuticals, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 57Moderate | TCONsell Tracon Pharmaceuticals, Inc. | Opaleye Management Inc. owner | $1.4M 4,764,008 shares | -110% | |
| 39Weak | TCONbuy Tracon Pharmaceuticals, Inc. | Charles Theuer President and CEO | $38k 50,999 shares | +15% | |
| 43Moderate | Tracon Pharmaceuticals, Inc. | Opaleye Management Inc. owner | $241k 174,508 shares | +4% | |
| 38Weak | Tracon Pharmaceuticals, Inc. | Charles Theuer President and CEO | $7,600 5,000 shares | +1% | |
| 30Weak | TCONbuy Tracon Pharmaceuticals, Inc. | Charles Theuer President and CEO | $11k 6,800 shares | +2% | |
| 25Weak | TCONbuy Tracon Pharmaceuticals, Inc. | Scott B. Brown Chief Financial Officer | $5,215 3,500 shares | +19% | |
| 42Moderate | Tracon Pharmaceuticals, Inc. | Opaleye Management Inc. owner | $210k 167,500 shares | +4% | |
| 46Moderate | Tracon Pharmaceuticals, Inc. | Charles Theuer President and CEO | $30k 23,000 shares | +7% | |
| 12Weak | TCONsell Tracon Pharmaceuticals, Inc. | Opaleye Management Inc. owner | $2,216 1,539 shares | -0% | |
| 30Weak | TCONbuy Tracon Pharmaceuticals, Inc. | Charles Theuer President and CEO | $20k 13,900 shares | +5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.